MannKind Corp
MNKD
#4977
Rank
โ‚ฌ1.49 B
Marketcap
4,88ย โ‚ฌ
Share price
-0.17%
Change (1 day)
-13.70%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): โ‚ฌ28.12 Million

According to MannKind Corp's latest financial reports the company's current earnings are โ‚ฌ0.31 Billion. In 2024 the company made an earning of โ‚ฌ25.74 Million, an increase over its 2023 earnings that were of -โ‚ฌ8.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ28.12 M9.26%
2024 โ‚ฌ25.74 M-394.09%
2023 -โ‚ฌ8.76 Million-88.13%
2022 -โ‚ฌ73.74 Million8%
2021 -โ‚ฌ68.27 Million40.84%
2020 -โ‚ฌ48.48 Million10.7%
2019 -โ‚ฌ43.79 Million-40.16%
2018 -โ‚ฌ73.18 Million-26.04%
2017 -โ‚ฌ98.94 Million-193.33%
2016 โ‚ฌ0.10 B-134.11%
2015 -โ‚ฌ0.32 Billion85.72%
2014 -โ‚ฌ0.17 Billion3.6%
2013 -โ‚ฌ0.17 Billion12.79%
2012 -โ‚ฌ0.15 Billion5.58%
2011 -โ‚ฌ0.14 Billion-5.72%
2010 -โ‚ฌ0.15 Billion-22.51%
2009 -โ‚ฌ0.19 Billion-27.37%
2008 -โ‚ฌ0.26 Billion3.36%
2007 -โ‚ฌ0.25 Billion27.18%
2006 -โ‚ฌ0.2 Billion101.63%
2005 -โ‚ฌ96.46 Million50.46%
2004 -โ‚ฌ64.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.99 B 38,401.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚ฌ17.58 B 67,618.55%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚ฌ18.98 B 73,003.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.47 B 74,908.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚ฌ0.62 B 2,323.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚ฌ95.99 Million-469.63%๐Ÿ‡บ๐Ÿ‡ธ USA